The clinical pro~le and course of documented cases of idiopathiC dilated cardiomyopathy in children have been poorly characterized. Twenty-four pati~nts (median age 2 years, range < 1 month to 18 years) with idiopathic dilated cardiomyopathy were identified from Mayo Clinic records from 1973 to 1982. The most common pr~sen tation was congestive heart failure (92% of patients). Echocardiography (22 patients) generally revealed a di• lated left ventricle with re,duced fractional shortening (inean 14%) and ejection fractlon (mean 26%); Two• dimensional echocardiographic evidence of left ventric• ular thrombus was present in 3 (23%) of 13 patients. Median cardiac index and left ventricular end-diastolic pressure (19 patients) were 2,5 iiters/min per m 2 and 22 mm Hg, respectively. Myocardial biopsy in eight pa• tients showed nonspecific findilJ.gs without active inflam• mation or evidence of endocardial fibroelastosis.
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On follow-up (rhean duration 33 months, range 0 to 149), systemic arterial emboiism had occurred in 2 (8%)
The cljnical characteristics and natural history of adults with idiopathic dilated cardioinyopathy are well described (1) (2) (3) . Few reports (4-9) have focused on idiopathic dilated car• diomyopattiy in patients younger than 20 years of age. The purpose of this report is to determine the natural history and predictors of death and survival in children with idiopathic dilated cardiomyopathy.
Methods
Patient selection. Mayo Clinic records from January 1973 to December 1982 (i 0 years) were reviewed to identify of 24 patients. Fifteen of 24 patients had died (63% survival at 1 year and 34 % survival at 5 years of follow• up). The cause of death was congestive heart failure in 11, complications after cardiac transplantation in 3 and sudden cardiac death in 1. Nine patients are alive at a mean follow-up time of 65 months (range 26 to 149); five are asymptomatic. Serial determination of left ventric• uhir systolic function, available in all survivors, showed improvement in six patients and no significant change in three. Severe mitral inshfficiency Was present only in patients who ultimately died. A recent viral syndrome was noted more frequently .in patients who survived. There were no clinical or laboratory variables that were sensitive and specific predictors of outcome. Although the prognosis of idiopathic dilated cardiomyopathy in children is usuaily grave, a minority show unpredictable clinical improvement.
(J Am Coil CardioI1985; 6:1126-31) cases of idiopathic dilated cardiotnyopathy in patients youn• ger than 20 years of age at the time of presentation to ttie Mayo Clinic or related hospitals. All patients with clinical or laboratory evidence of left ventricular dysfunction of uncertain origin were assessed in detail. Myocardial dys• function due to congenital cardiac lesions, valvular defects or suspected or iderttified metabolic or toxic causes were excluded. Patients with transient clinical and cardiac ab• normalities consistent with myocarditis were excluded.
The medical history of the 24 selected patients was re• viewed to determine age at onset of symptoms, symptoms, physical findings, clinical course, laboratory studies (chest X-ray film, electrocardiogram, echocardiogram and cardiac catheterization), treatment and outcome. Follow-up was by repeated examinations at the Mayo Clinic or letters from the patient's personal physician. The most recent appraisal of functional status included conversation by telephone with the patient's family or personal physician in five patients not followed up at the Mayo Clinic.
Analysis of data.
The variables analyzed in each patient for association with survival were sex, age at onset, recent viral syndrome, cardiothoracic ratio on chest X-ray film, electrocardiographic variables (left ventricular hypertrophy, ST -T wave abnormalities and ventricular arrhythmias), echocardiographic variables (fractional shortening, ejection fraction, left atrial size and left ventricular thrombus) and cardiac catheterization variables (left ventricular end-dia• stolic pressure, cardiac index and presence of severe mitral regurgitation), The echocardiographic ejection fraction was calculated using a modified method of Quinones et ai, (10) , The univariate statistical significance of variables analyzed for prediction of survival was judged by the log-rank test for life tables for discrete variables and the Cox proportional hazards model for continuous variables. Survival was es• timated by the product limit (Kaplan-Meier) method.
Results
Demographic profile and presentation of study pa• tients. We identified 24 patients younger than 20 years of age with a diagnosis of idiopathic dilated cardiomyopathy; Echocardlograms (M-mode in 20, two-dimensional in 13) were obtained in 22 patients (Table 2) . All echocardio• grams demonstrated depressed or borderline systoliC func• tion (that is, fractional shortening and ejection fraction). Mean fractional shortening was 14% (range 3 to 30%, nor• mal 31 to 45%) and ejection fraction was 26% (range 5 to 51 %, normal 2:: 55%). Left atrial enlargement was noted in 13 (54%). of 22 patients. Two-dimensional echocardio• graphic studies (13 patients) or left ventricular angiograms (15 patients) at presentation demonstrated global left ven• tricular dysfunction without major regional wall abnormal• ities. Two-dimensional echocardiography showed evidence of intracavitary thrombus in 3 (23%) of 13 patients.
Cardiac catheterization was performed in 16 patients at (Fig, 1) was 63% at 1 year, 50% at 2 years and 34% at 5 years of follow-up, The cause of death was intractable congestive heart failure in II, sudden death presumably secondary to a ventricular arrhythmia in 1 and death at or in the immediate postoperative period of cardiac transplan• tation in 3. Autopsy data were reviewed at the Mayo Clinic in five patients and all had a dilated heart without specific etiologic features.
Nine patients are alive and five of these are asympto• matic. The average duration of follow-up for the survivors is 65 months (range 26 to 149). Four asymptomatic patients (Cases 19, 20, 22 and 23) previously had symptoms of congestive heart failure; one patient (Case 17) presented with asymptomatic cardiomegaly. In the former four pa• tients, symptoms disappeared 3 to 24 months after presen• tation. In two of these patients (Cases 19 and 20), chest X• ray film showed that cardiomegaly had resolved. Follow• up assessment of left ventricular function, available in all survivors (echocardiography in seven, exercise radionuclide angiography in one and left ventriculography at cardiac cath• eterization in one), showed normal left ventricular function in one, improved (210% increase in ejection fraction) but abnormal left ventricular function in five and no significant change in three ( Table 2) . There was no evidence of left ventricular thrombus on follow-up two-dimensional echo• cardiography in seven patients. Three patients (Cases 16, 18 and 21) are in stable condition with New York Heart Association functional class II to III symptoms. One patient (Case 24) remains on treatment for ventricular arrhythmias without symptoms of congestive heart failure. 
Discussion
Prior reports. Greenwood et al. (4) reviewed 161 pe• diatric patients with "primary myocardial disease" seen at a Boston medical center from 1945 to 1974 and followed up for a mean period of 41 months. They reported that approximately one-third died, one-third recovered and one• third had chronic symptoms. This preechocardiographic study utilized cardiac catheterization in a small number of patients and included patients with diagnoses of endocardial fibro• elastosis, myocarditis and restrictive cardiomyopathy. Ma• ron and Roberts (5) discussed idiopathic dilated cardio• myopathy in a review of cardiomyopathy in the first two decades of life, but concentrated on pathologic features with little discussion of other clinical data, including prognosis. The report of Doshi and Lodge (6) of nine patients with idiopathic dilated cardiomyopathy also described a patho• logic series. Harris et al. (7) reported on eight patients with a dilated form of idiopathic nonobstructive cardiomyopathy. Follow-up study revealed death in five patients with two patients becoming asymptomatic. Van Der Hauwaert et al. (9) recently reported echocardiographic findings in patients who survived at least 2 years after presenting with conges• tive heart failure, left ventricular hypertrophy and cardio• megaly of uncertain origin before the age of 18 months. Follow-up data were available in 32 patients originally iden• tified and revealed 12 deaths (mortality rate 38%) at 4.5 to 7 years follow-up.
T ALIERCIO ET AL. DILATED CARDIOMYOPATHY IN THE YOUNG Characterization of study group. In this study, we ex• amined the clinical characteristics and outcome of a group of pediatric patients with dilated cardiomyopathy of uncer• tain origin. Twenty-four patients aged less than I month to 18 years were identified. Clinical diagnoses were confirmed by echocardiography, cardiac catheterization data or au• topsy. Patients with known endocardial fibroelastosis, my• ocarditis or myocardial dysfunction as a result of known causes were not included. Twelve patients did present at less than 2 years of age and seven of these had electrocar• diographic evidence of left ventricular hypertrophy. A di• lated form of endocardial fibroelastosis could not be ruled out with certainty in this latter group. Three of these patients had myocardial biopsy with no evidence of endocardial fi• broelastosis. Approximately half (13 of 24) of our patients had the onset of symptoms in close proximity to a nonspe• cific illness ascribed to a viral syndrome, and this raises the possibility of acute myocarditis as the original pathophy• siologic mechanism in these patients. Myocardial biopsy in six of these patients showed no evidence of active myo• carditis. Coxsackie B titers were not obtained.
Outcome and predictors of survival. Follow-up dem• onstrated a grave prognosis in this patient group with 63% survival at I year and 34% survival at 5 years (Fig. I) . Fuster et al. (1) reported a comparable survival rate of 37% at 5 years' follow-up in adult patients with idiopathic dilated cardiomyopathy. Intractable congestive heart failure was the most frequent cause of death in our series. Congestive heart failure is commonly the cause of death in adults with idio• pathic dilated cardiomyopathy, although a recent study (12) reported a 50% incidence of sudden death.
Whether an individual patient's ultimate outcome is de• pendent on differences in the severity or progression of the disease process, differences in host adaptation or other fac• tors is speculative. The clinical data at presentation did not enable us to adequately predict a patient's clinical course. Severe mitral insufficiency at angiography was observed only in three patients who ultimately died. This variable was insensitive in predicting poor outcome. Recent viral symptoms were noted more frequently in survivors; this finding had modest statistical significance, and its impor• tance is questionable. A febrile, respiratory illness may stress an abnormal but previously compensated heart and produce cardiac symptoms. Recent viral symptoms may also identify some patients who have developed cardiomyopathy related to myocarditis. The outcome of infants with definite acute myocarditis is generally not favorable (13) . The frequency of mild or asymptomatic myocarditis in infants and children is unknown and conceivably may have been the original cardiac lesion in some of our patients. As a predictor of survival, the variable of recent viral symptoms was 78% sensitive and 60% specific. (14) of adult patients with dilated cardiomyopathy appeared to identify a group with longer survival. In our study, 5 year survival in groups with and without electrocardiographic evidence of left ventricular hypertrophy was identical (34%). Thus, there was no ap• parent benefit with regard to survival from the presence of electrocardiographic evidence of left ventricular hypertrophy.
Adults with idiopathic dilated cardiomyopathy who have very poor ventricular function and marked hemodynamic abnormalities usually fare poorly (1) . Initial echocardio• graphic variables of systolic function (fractional shortening and ejection fraction) as well as hemodynamic data derived from cardiac catheterization were not different in survivors and nonsurvivors in our series.
Left ventricular thrombus and arterial emboliza• tion. Three (23%) of 13 patients with two-dimensional echocardiographic examinations had evidence of intracav• itary thrombus. Two other patients (8%) had definite arterial embolization. Transient abnormalities related to arterial em• bolization may have occurred in some of the younger pa• tients but was undetected because these patients are usually poor historians. Other investigations (1, 8, 15) in adults and children with dilated cardiomyopathy have reported an in• cidence of arterial embolization ranging from 17 to 38%. Anticoagulant therapy in adults with idiopathic dilated car• diomyopathy decreases the incidence of arterial emboliza• tion (1) . Anticoagulant therapy in children with idiopathic dilated cardiomyopathy should be considered in the presence of severely depressed left ventricular function.
Conclusion. Idiopathic dilated cardiomyopathy in the young has a poor prognosis when the patient presents with congestive heart failure. Some patients survive and show improvement, but the clinical indexes examined in this study showed no good predictors of survival. Whether more so• phisticated and recently developed techniques can identify predictors of survival is unknown. Patients who became asymptomatic during the follow-up period did so 3 to 24 months after presentation. A longer follow-up time will be necessary to see if these patients remain symptom-free.
